10-118311231-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000369183.9(FAM204A):c.626G>A(p.Arg209Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000752 in 1,609,696 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000369183.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM204A | NM_022063.3 | c.626G>A | p.Arg209Gln | missense_variant | 8/9 | ENST00000369183.9 | NP_071346.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM204A | ENST00000369183.9 | c.626G>A | p.Arg209Gln | missense_variant | 8/9 | 1 | NM_022063.3 | ENSP00000358183 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 151978Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000484 AC: 12AN: 247758Hom.: 0 AF XY: 0.0000673 AC XY: 9AN XY: 133820
GnomAD4 exome AF: 0.0000768 AC: 112AN: 1457600Hom.: 0 Cov.: 34 AF XY: 0.0000662 AC XY: 48AN XY: 724856
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152096Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.626G>A (p.R209Q) alteration is located in exon 8 (coding exon 6) of the FAM204A gene. This alteration results from a G to A substitution at nucleotide position 626, causing the arginine (R) at amino acid position 209 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at